Home > Financial Ratios > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Fixed Capital/Sales

    Back to All Ratios
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2017Mar2016
   Fixed Capital/Sales(x) 0.450.450.440.470.44

What is the latest Fixed Capital/Sales ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest Fixed Capital/Sales ratio of SYNCOM FORMULATIONS (INDIA) is 0.45 based on Mar2024 Consolidated results.
Year Fixed Capital/Sales
Mar20240.45
Mar20230.45
Mar20220.44
Mar20170.47
Mar20160.44

How is Fixed Capital/Sales of SYNCOM FORMULATIONS (INDIA) Trending?

Years Fixed Capital/Sales % Change
Mar2024 0.45
0.00
Mar2023 0.45
2.27
Mar2022 0.44
-6.38
Mar2017 0.47
6.82
Mar2016 0.44 -

Other Financial Ratios of SYNCOM FORMULATIONS (INDIA)


Compare Fixed Capital/Sales ratio of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,442.9 Cr -9.7% -13% 7.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹382,430.0 Cr -3% -8.7% 4.1% Stock Analytics
DIVIS LABORATORIES ₹145,410.0 Cr -4.7% -4.5% 58.5% Stock Analytics
CIPLA ₹113,950.0 Cr -4.3% -3.2% -3.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹99,682.3 Cr -3% -12.3% 13.8% Stock Analytics
DR REDDYS LABORATORIES ₹93,261.6 Cr -3% -6.5% -12.7% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

-9.7%

-13%

7.7%

SENSEX

-3.4%

-4.4%

0.6%


You may also like the below Video Courses